Health
Trial: No Need to Stop RAS Inhibitors in COVID-19 – MedPage Today
REPLACE COVID trial supports findings from BRACE CORONA
Hospitalized COVID-19 patients may safely continue taking their angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), according to the small REPLACE COVID trial.
The study’s primary hierarchical endpoint — a global rank score in which patients were ranked by the severity of their COVID disease course according to various biomarkers and clinical events, with a lower rank score meaning more severe COVID-19 hospitalization — was about the same whether people were…
-
Noosa News24 hours agoHeartbreaking CCTV shows father and son moments before fatal crash in Regents Park, Queensland
-
General23 hours agoTwo men involved in fatal helicopter accident charged over stealing crocodile eggs from Kakadu National Park
-
Noosa News23 hours agoFamily’s heartbreak after Trevor Doyle found dead in park in Logan
-
General11 hours agoQueensland announced as 2027 Women’s Softball World Cup host in first Australian event since 1965